ConductScience.org, home

Paper22621925

Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways.

Sears CR and 1 other. J Biol Chem, 2012. Cited by 54 papers, by iCite.

Cite this record

ConductScience Library. Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways. Papers, record 22621925. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22621925

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Complex cisplatin-double strand break (DSB) lesions directly impair cellular non-homologous end-joining (NHEJ) independent of downstream damage response (DDR) pathways.
PubMed
Journal
J Biol Chem
PubMed
Year
2012
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
54
iCite
Relative citation ratio, by iCite
1.37
iCite
Revised in PubMed
2024-03-18
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Sears CRCatherine R
2Turchi JJJohn J

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CisplatinMajor topic
DNA Breaks, Double-StrandedMajor topic
Cell Line, Tumor
Flow Cytometry
Humans
Microscopy, Fluorescence
Signal Transduction

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
R01 CA082741NCI NIH HHSUnited StatesR01CA082741PubMed and NIH
CA082741NCI NIH HHSUnited StatesR01CA082741PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16196777Alteration and activation of sequence-specific cleavage of DNA by bleomycin in the presence of the antitumor drug cis-diamminedichloroplatinum(II).Proc Natl Acad Sci U S A1983https://conductscience.org/library/papers/6196777PubMed
215872216Inhibition of double-strand break non-homologous end-joining by cisplatin adducts in human cell extracts.Nucleic Acids Res2005https://conductscience.org/library/papers/15872216PubMed
320142431Alternative end-joining catalyzes class switch recombination in the absence of both Ku70 and DNA ligase 4.J Exp Med2010https://conductscience.org/library/papers/20142431PubMed
410329699Replication protein A (RPA) binding to duplex cisplatin-damaged DNA is mediated through the generation of single-stranded DNA.J Biol Chem1999https://conductscience.org/library/papers/10329699PubMed
59826654DNA end-joining catalyzed by human cell-free extracts.Proc Natl Acad Sci U S A1998https://conductscience.org/library/papers/9826654PubMed
621376743Choosing the right path: does DNA-PK help make the decision?Mutat Res2011https://conductscience.org/library/papers/21376743PubMed
720351327Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.J Clin Oncol2010https://conductscience.org/library/papers/20351327PubMed
83491805The effect of combined treatment with platinum complexes and ionizing radiation on DNA in vitro.Int J Radiat Biol Relat Stud Phys Chem Med1986https://conductscience.org/library/papers/3491805PubMed
917898768Rag mutations reveal robust alternative end joining.Nature2007https://conductscience.org/library/papers/17898768PubMed
108662830Human Ku autoantigen binds cisplatin-damaged DNA but fails to stimulate human DNA-activated protein kinase.J Biol Chem1996https://conductscience.org/library/papers/8662830PubMed
1114576837Cisplatin: mode of cytotoxic action and molecular basis of resistance.Oncogene2003https://conductscience.org/library/papers/14576837PubMed
1212829693Behavior of T7 RNA polymerase and mammalian RNA polymerase II at site-specific cisplatin adducts in the template DNA.J Biol Chem2003https://conductscience.org/library/papers/12829693PubMed
138544761Photochemical production of double-strand breaks in cellular DNA.Mutagenesis1995https://conductscience.org/library/papers/8544761PubMed
149338102Maintaining genetic stability through TP53 mediated checkpoint control.Cancer Surv1997https://conductscience.org/library/papers/9338102PubMed
1511095672Cisplatin-DNA adducts inhibit translocation of the Ku subunits of DNA-PK.Nucleic Acids Res2000https://conductscience.org/library/papers/11095672PubMed
168648250Concomitant low dose-rate irradiation and cisplatin treatment in ovarian carcinoma cell lines sensitive and resistant to cisplatin treatment.Int J Radiat Biol1996https://conductscience.org/library/papers/8648250PubMed
1712020431Examining the non-homologous repair process following cisplatin and radiation treatments.Int J Radiat Biol2002https://conductscience.org/library/papers/12020431PubMed
1821296855Global cancer statistics.CA Cancer J Clin2011https://conductscience.org/library/papers/21296855PubMed
1917873173Treatment of non-small cell lung cancer, stage IIIB: ACCP evidence-based clinical practice guidelines (2nd edition).Chest2007https://conductscience.org/library/papers/17873173PubMed
208519652Carboplatin- and cisplatin-induced potentiation of moderate-dose radiation cytotoxicity in human lung cancer cell lines.Br J Cancer1995https://conductscience.org/library/papers/8519652PubMed

See all 38 referencesDownload CSV of references

Cited by38

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 54 citations.

PMIDTitleJournalYearIn PapersSource
42619032Unveiling the New Trick for Epigenetic Drug: Radiation Enhancement of Prostate Cancer by the EZH2 Inhibitor Tazemetostat.J Cell Mol Med2026https://conductscience.org/library/papers/42619032PubMed
41854291Cell-cycle-specific lesion evolution rather than inhibition of double-strand-break repair underpins cisplatin radiosensitization.Mol Oncol2026https://conductscience.org/library/papers/41854291PubMed
41201971T2R5 Agonist Phendione Decreases Cell Viability and Induces Apoptosis in Head and Neck Squamous Cell Carcinoma.Mol Cancer Ther2026https://conductscience.org/library/papers/41201971PubMed
40422185Effects of Cisplatin on the Radiation Response and DNA Damage Markers in Peripheral Blood Lymphocytes Ex Vivo.Cells2025https://conductscience.org/library/papers/40422185PubMed
40402512Mutagenic Impact and Evolutionary Influence of Chemoradiotherapy in Hematologic Malignancies.Blood Cancer Discov2025https://conductscience.org/library/papers/40402512PubMed
39931862GCN2 in Cancer: Molecular Mechanisms to Therapeutic Potential.Curr Cancer Drug Targets2026https://conductscience.org/library/papers/39931862PubMed
38947172Chemo-small extracellular vesicles released in cisplatin-resistance ovarian cancer cells are regulated by the lysosomal function.J Extracell Biol2024https://conductscience.org/library/papers/38947172PubMed
38486992Metal nanoparticles for cancer therapy: Precision targeting of DNA damage.Acta Pharm Sin B2024https://conductscience.org/library/papers/38486992PubMed
38010604Nutritional Support of Crocin on Neurobehavioral Disabilities Induced by Cisplatin-Based Chemotherapy in Rats.Neurochem Res2024https://conductscience.org/library/papers/38010604PubMed
36614204Spectroscopic Characterization and Biological Activity of Hesperetin Schiff Bases and Their Cu(II) Complexes.Int J Mol Sci2023https://conductscience.org/library/papers/36614204PubMed
36450764A nuclease-mimetic platinum nanozyme induces concurrent DNA platination and oxidative cleavage to overcome cancer drug resistance.Nat Commun2022https://conductscience.org/library/papers/36450764PubMed
36335317HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.BMC Oral Health2022https://conductscience.org/library/papers/36335317PubMed
35806243Can Cisplatin Therapy Be Improved? Pathways That Can Be Targeted.Int J Mol Sci2022https://conductscience.org/library/papers/35806243PubMed
35435331Identification of a Crosstalk among TGR5, GLIS2, and TP53 Signaling Pathways in the Control of Undifferentiated Germ Cell Homeostasis and Chemoresistance.Adv Sci (Weinh)2022https://conductscience.org/library/papers/35435331PubMed
35085879DNA Repair Capacity for Personalizing Risk and Treatment Response - Assay Development and Optimization in Human Peripheral Blood Mononuclear Cells (PBMCs).DNA Repair (Amst)2022https://conductscience.org/library/papers/35085879PubMed
35018240DHMEQ enhances the cytotoxic effect of cisplatin and carboplatin in ovarian cancer cell lines.Am J Cancer Res2021https://conductscience.org/library/papers/35018240PubMed
34685687
Cisplatin Reduces the Frequencies of Radiotherapy-Induced Micronuclei in Peripheral Blood Lymphocytes of Patients with Gynaecological Cancer: Possible Implications for the Risk of Second Malignant Neoplasms.
Cells2021https://conductscience.org/library/papers/34685687PubMed
34359683Targeting BRF2 in Cancer Using Repurposed Drugs.Cancers (Basel)2021https://conductscience.org/library/papers/34359683PubMed
34250022The Role of Tumour Metabolism in Cisplatin Resistance.Front Mol Biosci2021https://conductscience.org/library/papers/34250022PubMed
33512317DNA damage-how and why we age?Elife2021https://conductscience.org/library/papers/33512317PubMed

See all 38 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22621925

GET https://conductscience.org/api/papers/v1/22621925/references?page=2